Showing 1 - 19 results of 19 for search 'L. Pei', query time: 0.05s
Refine Results
-
1
-
2
-
3
IONOSPHERIC TEMPORAL-SPATIAL CORRELATION ANALYSIS USING GNSS NETWORKS OVER CHINA by Y. Xiang, Z. Li, N. Wang, L. Pei, W. Yu
Published 2023-12-01
Article -
4
Segmented Cladding Fiber With a High-Index Ring in Core for Wideband Single-Mode Operation in Any Bending Orientation by Z. Guo, L. Pei, T. Ning, J. Zheng, J. Li, J. Wang
Published 2021-01-01
Article -
5
ASSESSMENT OF BUILDINGS AND ELECTRICAL FACILITIES DAMAGED BY FLOOD AND EARTHQUAKE FROM SATELLITE IMAGERY by Y. Ma, F. Zhou, G. Wen, H. Gen, R. Huang, G. Liu, L. Pei
Published 2022-04-01
Article -
6
A 3D LIDAR RECONSTRUCTION APPROACH FOR VEGETATION DETECTION IN POWER TRANSMISSION NETWORKS by Y. Ma, F. Zhou, G. Wen, H. Gen, R. Huang, Q. Wu, L. Pei
Published 2022-04-01
Article -
7
-
8
-
9
Experimental study of multi-bubble hydraulic efficiency of spark-generated bubbles by L. C. Zhang, S. D. Ding, Y. L. Pei, K. Liu, X. M. Zhang, Y. Z. Jin, Z. C. Zhu, K. P. Yan
Published 2022-09-01
Article -
10
PB2020: MAJESTEC-3: RANDOMIZED, PHASE 3 STUDY OF TECLISTAMAB PLUS DARATUMUMAB VERSUS DPD OR DVD IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA by M. V. Mateos, N. Bahlis, L. Costa, A. Perrot, L. Pei, M. Rubin, K. Lantz, W. Sun, M. Jaffe, R. Kobos, A. Nooka
Published 2022-06-01
Article -
11
-
12
PB2013: TECLISTAMAB COMPARED WITH REAL-WORLD THERAPIES IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA by A. Krishnan, A. K. Nooka, A. Chari, A. Garfall, T. Martin, S. Nair, X. Lin, K. Qi, A. Londhe, L. Pei, E. Ammann, R. Kobos, J. Smit, T. Parekh, M. Slavcev, S. Usmani
Published 2022-06-01
Article -
13
P972: INDIRECT COMPARISON OF TECLISTIMAB IN MAJESTEC-1 VERSUS PHYSICIAN’S CHOICE OF THERAPY IN LONG-TERM FOLLOW-UP OF TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA IN D... by K. Weisel, A. Chari, S. Z. Usmani, H. Goldschmidt, M.-V. Mateos, K. Qi, A. Londhe, S. Nair, X. Lin, L. Pei, E. Ammann, R. Kobos, J. Smit, T. Parekh, M. Slavcev, P. Moreau
Published 2022-06-01
Article -
14
P935: REAL WORLD COMPARATIVE ANALYSIS OF THE EFFICACY OF TECLISTAMAB VERSUS CURRENT TREATMENTS IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE L... by H. Einsele, P. Moreau, M. Delforge, N. W. van de Donk, F. Ghilotti, J. Diels, A. Elsada, V. Strulev, L. Pei, R. Kobos, J. Smit, M. Slavcev, K. Weisel, M.-V. Mateos
Published 2022-06-01
Article -
15
S184: EVALUATING TECLISTAMAB IN PATIENTS WITH RELAPSED/ REFRACTORY MULTIPLE MYELOMA FOLLOWING EXPOSURE TO OTHER B-CELL MATURATION ANTIGEN (BCMA)-TARGETED AGENTS by C. Touzeau, A. Krishnan, P. Moreau, A. Perrot, S. Z. Usmani, S. Manier, M. Cavo, C. Martinez-Chamorro, A. Nooka, T. Martin, L. Karlin, X. Leleu, N. Bahlis, B. Besemer, L. Pei, R. Verona, S. Girgis, C. Uhlar, R. Kobos, A. Garfall
Published 2022-06-01
Article -
16
P898: COMPARISON OF TECLISTAMAB WITH BELANTAMAB MAFODOTIN IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA USING MATCHING-ADJUSTED INDIRECT TREATMENT COMP... by M. Delforge, S. Z. Usmani, N. W. van de Donk, A. L. Garfall, P. Moreau, A. Oriol, A. K. Nooka, L. Rosinol, N. Bahlis, P. Rodriguez-Otero, T. Martin, J. Diels, S. Van Sanden, L. Pei, E. Ammann, R. Kobos, M. Slavcev, J. Smit, A. Londhe, A. Krishnan
Published 2022-06-01
Article -
17
PB2014: TECLISTAMAB VS SELINEXOR-DEXAMETHASONE IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MATCHING-ADJUSTED INDIRECT COMPARISON by L. Rosinol, S. Z. Usmani, N. Bahlis, A. Y. Krishnan, A. K. Nooka, A. Oriol, M. Delforge, A. L. Garfall, N. W. van de Donk, P. Rodríguez Otero, T. G. Martin, J. Diels, S. Van Sanden, L. Pei, E. Ammann, R. Kobos, M. Slavcev, J. Smit, A. Londhe, P. Moreau
Published 2022-06-01
Article -
18
P32 MAJESTEC-1: CORRELATIVE ANALYSES OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) by N. van de Donk, D. Cortes-Selva, T. Casneuf, D. Vishwamitra, S. Stein, T. Perova, E. Ramos, L. Van Steenbergen, R. Boominathan, O. Lau, C. Davis, A. Banerjee, T. Stephenson, C. Uhlar, R. Kobos, J. Goldberg, L. Pei, D. Trancucci, S. Girgis, S.X.W. Lin, L.S. Wu, P. Moreau, S. Usmani, N.J. Bahlis, R. Verona
Published 2023-05-01
Article -
19
P06: UPDATED RESULTS FROM THE PHASE 1/2 MAJESTEC-1 STUDY OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOM... by R Popat, S Usmani, A Garfall, N van de Donk, H Nahi, J San-Miguel, A Oriol, A Nooka, T Martin, L Rosinol, A Chari, L Karlin, L Benboubker, M Mateos, N Bahlis, P Moreau, B Besemer, J Martínez-López, S Sidana, L Pei, D Trancucci, R Verona, S Girgis, Y Olyslager, M Jaffe, C Uhlar, T Stephenson, R Van Rampelbergh, A Banerjee, J Goldberg, R Kobos, A Krishnan
Published 2022-04-01
Article